Picture of BioInvent International AB logo

BINV BioInvent International AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-138-75.5-278-50.9-370
Depreciation
Non-Cash Items0.379-0.0411.141.792.95
Other Non-Cash Items
Changes in Working Capital0.430.88916.8-5.9411.9
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-125-62.6-246-40.3-338
Capital Expenditures-3.84-6.7-13.3-12.4-13.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-454-61673
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-3.84-6.7-468-62959.7
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21464589527323.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash85.1575181-396-255